General Dynamics is a diversified defense and Gulfstream aerospace prime on a 48% year-over-year backlog surge to $131B Investing.com· apr 2026. Four straight EPS beats, a raised 2026 guide ($16.45–$16.55), an investment-grade balance sheet and a shrinking share count make this a clean quality-compounder setup — not a hype trade. Price sits above all three key EMAs: EMA20 ($347.48) > EMA200 ($343.91) > EMA50 ($341.09), with the EMA20 pulling away from the cluster — a constructive intermediate structure. RSI 51.7 is neutral-bullish, showing momentum has cooled from overbought but remains above 50, and 4/4 earnings beats show an accelerating trajectory (Q1-2026: $4.10 vs $3.69 est, +11% beat). We rate this A+ — pristine fundamentals, no material compliance flags, and the trade math delivers a clean 3.6R to TP1 (6.3R to TP2) with the stop well-placed below the EMA50 cluster.
General Dynamics is one of the world's largest defense contractors, operating across four segments: Aerospace (Gulfstream business jets), Marine Systems (Columbia- and Virginia-class submarines, surface combatants), Combat Systems (Abrams tanks, Stryker and wheeled vehicles, munitions) and Technologies (GDIT IT services + Mission Systems). Roughly two-thirds of revenue is tied to long-cycle US and allied government programs, giving the business a backlog-driven, recurring-revenue character that smooths economic cycles StockAnalysis· jun 2026.
The Q1 2026 print captured the franchise at full stride: revenue of $13.5B (+10.3% YoY) with Marine Systems up 21% on submarine production and Aerospace delivering a record 38 first-quarter Gulfstream jets at a 15% margin GD IR· apr 2026. The structural moat — decades-long platform programs, deep government relationships and a $188B total estimated contract value — is exactly what makes GD a compounder rather than a cyclical trade.
| Metric | Value | Signal |
|---|---|---|
| Revenue (TTM) | $53.8B | +10% YoY |
| EBITDA (TTM) | $6.49B | Expanding |
| Operating Margin | 10.5% | Steady |
| Net Margin | 8.1% | Healthy |
| Net Income (TTM) | $4.34B | Growing |
| EPS (TTM) | $15.89 | 4 beats |
| ROE | 18.0% | Strong |
| Cash | $3.65B | Solid |
| Total Debt | $9.83B | D/E 0.38 |
| Trailing P/E | 22.0x | Reasonable |
| Fwd P/E | 20.8x | Fair for compounder |
| Analyst Target | $393 ($313–$444) | +12% upside |
GD scores well on growth, cash generation and quality (18.0% ROE), with valuation that sits in the "fair" — not cheap, not stretched — zone. At 20.8x forward earnings against a backlog up 48% and a raised guide, you are paying a market-style multiple for above-market visibility.
| Price | $350.40 |
| RSI (14) | 51.7 |
| EMA 20 | $347.48 |
| EMA 50 | $341.09 |
| EMA 200 | $343.91 |
| ATR (14) | $8.17 |
| 52W High | $369.70 |
Constructive intermediate structure with price consolidating near its highs. All three EMAs sit below price: EMA20 ($347.48) > EMA200 ($343.91) > EMA50 ($341.09), with the EMA50 still catching up to the EMA200 after the recent advance. Price at $350.40 sits just above the EMA20, hugging the short-term average rather than extended above it. RSI at 51.7 is neutral-bullish — momentum has cooled from higher levels, resetting overbought conditions and providing a healthier launch pad. The stock is ~5.2% below the 52-week high of $369.70, with the recent pullback from $364 offering a more favorable entry than the prior breakout chase Yahoo Finance· jun 2026. ATR at $8.17 (~2.3%) implies normal volatility for a name of this size.
A diversified, investment-grade defense prime with a record backlog and no dilution overhang. The primary near-term risks are technical (extension/chasing) and policy (defense-budget headlines), not balance-sheet or franchise risk.
GD's downside is dominated by trade-timing (extension) and macro/policy headlines rather than anything structural. The balance sheet is investment-grade (D/E 0.38), there is no dilution machinery on EDGAR, beta is a defensive 0.34, and the $131B backlog hard-anchors forward revenue. That combination keeps the overall risk firmly in the moderate-low band SEC EDGAR· jun 2026.
This is a quality-compounder continuation trade, not a chase. GD is consolidating near its highs with price above all three EMAs, four consecutive EPS beats, and a 2026 guide that management raised after Q1 to $16.45–$16.55 Seeking Alpha· apr 2026. The $131B backlog (+48% YoY) and 2:1 book-to-bill underwrite the forward earnings power that justifies the 20.8x multiple. We enter near the EMA20 cluster ($348–$352), risking to $340.00 (below the EMA50 swing) for a clean 3.6R to $386.00 and a 6.3R stretch toward the analyst-target zone at $412.50.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
The entry, stop and target levels are illustrative trade parameters, not orders or guarantees. Prices and data are as of 14 June 2026 and may be stale by the time you read this — verify live quotes before acting.
Disclosure: The author and DailyTickers hold no position in GD and receive no compensation related to this security. We have no fiduciary relationship with readers.
Data sourced from Yahoo Finance, StockAnalysis.com, SEC EDGAR, company investor relations, and public market data as of 14 June 2026 (technicals updated 21 June 2026). Accuracy is not guaranteed.